Stay updated on Repotrectinib in Rearranged Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Repotrectinib in Rearranged Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Repotrectinib in Rearranged Solid Tumors Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The history now lists the latest site revision as v3.5.3, superseding the previous v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-30T16:26:47.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Revision: v3.5.2 was added and Revision: v3.5.0 was removed in the page history.
    Difference
    0.0%
    Check dated 2026-04-16T11:16:59.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The record history adds IPDSharing, Contacts/Locations, and Study Status in the latest update, and shows a deletion on 2025-07-10.
    Difference
    0.2%
    Check dated 2026-04-09T08:32:34.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    Revision v3.5.0 has been added to the history, and Revision v3.4.3 has been removed.
    Difference
    0.0%
    Check dated 2026-03-18T16:58:51.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    Added revision v3.4.3 and removed revision v3.4.2 from the history list.
    Difference
    0.0%
    Check dated 2026-03-11T16:32:07.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    The history shows a new Revision: v3.4.2 added and the prior government funding notice/banner removed. These changes affect only site-wide notices and do not modify the study data, eligibility, or results.
    Difference
    0.3%
    Check dated 2026-02-11T02:49:58.000Z thumbnail image

Stay in the know with updates to Repotrectinib in Rearranged Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Repotrectinib in Rearranged Solid Tumors Clinical Trial page.